STUDY OBJECTIVES: To determine whether a vaccination program in a pharmacist-managed secondary prevention lipid clinic increased influenza immunization rates in a high-risk population, and whether age or gender disparity existed among those vaccinated. DESIGN: Retrospective chart review. SETTING: Large, multispecialty, group practice. PATIENTS: A total of 476 and 266 patients seen at clinic visits during the 2003-2004 and 2004-2005 influenza seasons, respectively. MEASUREMENTS AND MAIN RESULTS: Immunization rates were compared before (2003-2004 influenza season) and after (2004-2005 influenza season) the implementation of the influenza vaccination program; chi2 analysis was used for all statistical inferences. Vaccination rates increased significantly from 39% to 76% (p<0.0001) after program implementation. No before-after difference in rates was noted based on gender. Before implementation, patients younger than 65 years were less likely versus those aged 65 years or older to receive the influenza vaccine (29% vs 58%, p<0.0001). Age disparity in vaccination rates was eliminated after initiation of the program. CONCLUSION: The pharmacist-managed program increased influenza vaccination rates in high-risk patients with cardiovascular disease in advance of the newly published secondary prevention guidelines. Age-related differences in the vaccination rates were eliminated after program implementation.
STUDY OBJECTIVES: To determine whether a vaccination program in a pharmacist-managed secondary prevention lipid clinic increased influenza immunization rates in a high-risk population, and whether age or gender disparity existed among those vaccinated. DESIGN: Retrospective chart review. SETTING: Large, multispecialty, group practice. PATIENTS: A total of 476 and 266 patients seen at clinic visits during the 2003-2004 and 2004-2005 influenza seasons, respectively. MEASUREMENTS AND MAIN RESULTS: Immunization rates were compared before (2003-2004 influenza season) and after (2004-2005 influenza season) the implementation of the influenza vaccination program; chi2 analysis was used for all statistical inferences. Vaccination rates increased significantly from 39% to 76% (p<0.0001) after program implementation. No before-after difference in rates was noted based on gender. Before implementation, patients younger than 65 years were less likely versus those aged 65 years or older to receive the influenza vaccine (29% vs 58%, p<0.0001). Age disparity in vaccination rates was eliminated after initiation of the program. CONCLUSION: The pharmacist-managed program increased influenza vaccination rates in high-risk patients with cardiovascular disease in advance of the newly published secondary prevention guidelines. Age-related differences in the vaccination rates were eliminated after program implementation.
Authors: D MacDougall; B A Halperin; J Isenor; D MacKinnon-Cameron; L Li; S A McNeil; J M Langley; S A Halperin Journal: Hum Vaccin Immunother Date: 2016-03-03 Impact factor: 3.452
Authors: Jennifer E Isenor; Tania A Alia; Jessica L Killen; Beverly A Billard; Beth A Halperin; Kathryn L Slayter; Shelly A McNeil; Donna MacDougall; Susan K Bowles Journal: Hum Vaccin Immunother Date: 2016-02-10 Impact factor: 3.452
Authors: Richard K Zimmerman; Steven M Albert; Mary Patricia Nowalk; Michael A Yonas; Faruque Ahmed Journal: Am J Prev Med Date: 2011-02 Impact factor: 5.043
Authors: Jennifer W Chow; Michael F Chicella; Anthony M Christensen; Carolyn S Moneymaker; John Harrington; James E Dice Journal: J Pediatr Pharmacol Ther Date: 2017 Sep-Oct
Authors: Junling Wang; Lindsay J Ford; La'Marcus Wingate; Sarah Frank Uroza; Nina Jaber; Cindy T Smith; Richard Randolph; Steve Lane; Stephan L Foster Journal: J Am Pharm Assoc (2003) Date: 2013 Jan-Feb
Authors: Steven M Albert; Mary Patricia Nowalk; Michael A Yonas; Richard K Zimmerman; Faruque Ahmed Journal: BMC Fam Pract Date: 2012-03-20 Impact factor: 2.497